Attovia Therapeutics, Inc (ATTO) insider trading
Every open-market stock purchase and sale by Attovia Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Colin Walsh (Director) and 1 other bought $45.6M in the last 90 days, more than doubling their stake.
- Goldman Sachs Group Inc (Insider) and 1 other sold $9M in the last 90 days.
Last 12 months: insiders bought $45.6M (4 buys) and sold $9M (4 sales). Last close $21.46 on Aug 27, 2026.
Recent ATTO insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Aug 6, 2026 | Colin Walsh (Director) | Bought | $8.5M |
| Aug 6, 2026 | Goldman Sachs Group Inc (Insider) | Bought | $8.5M |
| Aug 6, 2026 | Colin Walsh (Director) | Bought | $8.5M |
| Aug 6, 2026 | Goldman Sachs Group Inc (Insider) | Bought | $8.5M |
| Aug 6, 2026 | Colin Walsh (Director) | Bought (not open market) | — |
| Aug 6, 2026 | Colin Walsh (Director) | Bought (not open market) | — |
| Aug 6, 2026 | Goldman Sachs Group Inc (Insider) | Bought (not open market) | — |
| Aug 6, 2026 | Goldman Sachs Group Inc (Insider) | Bought (not open market) | — |
| Aug 6, 2026 | Goldman Sachs Group Inc (Insider) | Bought (not open market) | — |
| Aug 6, 2026 | Goldman Sachs Group Inc (Insider) | Bought (not open market) | — |
| Aug 6, 2026 | Goldman Sachs Group Inc (Insider) | Bought (not open market) | — |
| Aug 6, 2026 | Colin Walsh (Director) | Bought (not open market) | — |
| Aug 6, 2026 | Colin Walsh (Director) | Bought (not open market) | — |
| Aug 6, 2026 | Colin Walsh (Director) | Bought (not open market) | — |
| Aug 6, 2026 | Colin Walsh (Director) | Bought (not open market) | — |
| Aug 6, 2026 | Goldman Sachs Group Inc (Insider) | Bought (not open market) | — |
| Aug 6, 2026 | Colin Walsh (Director) | Bought (not open market) | — |
| Aug 6, 2026 | Goldman Sachs Group Inc (Insider) | Bought (not open market) | — |
| Aug 6, 2026 | Colin Walsh (Director) | Bought (not open market) | — |
| Aug 6, 2026 | Goldman Sachs Group Inc (Insider) | Bought (not open market) | — |
| Aug 5, 2026 | Colin Walsh (Director) | Bought | $1.8M |
| Aug 5, 2026 | Goldman Sachs Group Inc (Insider) | Bought | $1.8M |
| Aug 5, 2026 | Colin Walsh (Director) | Bought | $1.8M |
| Aug 5, 2026 | Goldman Sachs Group Inc (Insider) | Bought | $1.8M |
| Aug 5, 2026 | Goldman Sachs Group Inc (Insider) | Sold | $1.6M |
Who's trading ATTO
- Goldman Sachs Group Inc, Insider: bought $22.8M (10 buys), sold $4.5M (40 sales), last Aug 6, 2026
- Colin Walsh, Director: bought $22.8M (10 buys), sold $4.5M (40 sales), last Aug 6, 2026
- Hubert Chen, C-suite exec: other filings, last Aug 4, 2026
- Mitchell Gold, Insider: other filings, last Aug 4, 2026
- Zaneta Odrowaz, C-suite exec: other filings, last Aug 4, 2026
- Petter Veiby, C-suite exec: other filings, last Aug 4, 2026
Get free alerts when an insider at Attovia Therapeutics, Inc files a new trade →